<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2007-4085</journal-id>
<journal-title><![CDATA[Revista mexicana de urología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. urol.]]></abbrev-journal-title>
<issn>2007-4085</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Urología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2007-40852020000400002</article-id>
<article-id pub-id-type="doi">10.48193/revistamexicanadeurologa.v80i4.626</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Teleurología y experiencia en el diagnóstico de neoplasias urológicas en un hospital en el Norte de México]]></article-title>
<article-title xml:lang="en"><![CDATA[Experience with teleurology in the diagnosis of urologic neoplasias at a hospital in Northern Mexico]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González-Bonilla]]></surname>
<given-names><![CDATA[Eduardo Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cantú-Elizondo]]></surname>
<given-names><![CDATA[Jesús Héctor]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Halún-Treviño]]></surname>
<given-names><![CDATA[Antonio Nassim]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González-Oyervides]]></surname>
<given-names><![CDATA[Roberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Barrera-Juárez]]></surname>
<given-names><![CDATA[Eduardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Tecnológico y de Estudios Superiores de Monterrey Escuela de Medicina y Ciencias de la Salud ]]></institution>
<addr-line><![CDATA[Monterrey Nuevo León]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2020</year>
</pub-date>
<volume>80</volume>
<numero>4</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2007-40852020000400002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2007-40852020000400002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2007-40852020000400002&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Antecedentes: El cáncer genitourinario es un gran problema de salud global, los índices de mortalidad son mayores en países con menor desarrollo. México tiene una distribución geográfica compleja, haciendo difícil proveer servicios de salud en las comunidades rurales. En este estudio presentamos la experiencia obtenida tras brindar servicios médicos a través de telemedicina a comunidades alejadas, principalmente en el diagnóstico de neoplasias urológicas. Se espera que, al compartir nuestra experiencia, se desarrollen mejoras en el programa y en el proceso de diagnóstico de neoplasias urológicas en consulta de primer nivel, esto para mejorar la referencia oportuna de los pacientes.  Material y Métodos: Análisis descriptivo retrospectivo de las consultas urológicas otorgadas por el personal del servicio de urología a través de telemedicina de enero 2009 a mayo del 2017. Se examinaron los expedientes de los pacientes captados con sospecha de neoplasia urológica y se analizaron los datos de los pacientes en quienes el diagnóstico fue confirmado.  Resultados: Un total de 1,265 consultas fueron otorgadas por el servicio de urología a través de telemedicina en este periodo de tiempo. De estas, 696 fueron consultas de primera vez, y el resto subsecuentes. 59 pacientes tuvieron sospecha de cáncer genitourinario (8% de las consultas de primera vez), y se confirmó la enfermedad en 17 pacientes (2% de las consultas de primera vez). La neoplasia más prevalente fue cáncer de próstata con 6 casos (35%), el resto de los casos corresponden a cáncer vesical (29%), cáncer de pene (12%), cáncer testicular (12%), cáncer renal (6%) y cáncer urotelial del tracto urinario superior (6%). La edad promedio de los pacientes fue 65.7 años y el predominio de los casos fue representado por el sexo masculino con 15 casos. La mayoría de los casos fueron diagnosticados en estadios clínicos avanzados.  Conclusión: En nuestra experiencia, la telemedicina tiene un papel limitado en el diagnóstico oportuno de cáncer genitourinario, ya que la mayoría de los casos presentados fueron diagnosticados en estadios avanzados.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Background: Genitourinary cancer is a great health problem worldwide, and mortality rates are higher in less developed countries. Mexico&#8217;s geographic distribution is complex, making it difficult to provide health services to rural communities. In the present study, we present the experience in providing medical services to remote communities through telemedicine, mainly in relation to the diagnosis of urologic neoplasias. By sharing our experience, we hope the program, as well as the process of primary care diagnosis of urologic neoplasias, can be improved, enhancing opportune patient referral.  Materials and Methods: A retrospective, descriptive analysis of the urology consultations carried out by the urology service personnel through telemedicine, within the time frame of January 2009 to May 2017, was conducted. The case records of patients suspected of urologic neoplasia were examined and the data of patients in whom the diagnosis was confirmed were analyzed.  Results: A total of 1,265 consultations were given by the urology service through telemedicine during the study period. Of those, 696 were first-time consultations and the rest were subsequent appointments. Fifty-nine patients were suspected of having genitourinary cancer (8% of the first-time consultations) and the disease was confirmed in 17 patients (2% of the first-time consultations). The most prevalent neoplasia was prostate cancer, presenting in 6 patients (35%), and the remaining cases corresponded to bladder cancer (29%), penile cancer (12%), testicular cancer (12%), kidney cancer (6%), and urothelial cancer of the upper urinary tract (6%). Mean patient age was 65.7 years, with a predominance of men (n = 15). The majority of cases were diagnosed in clinically advanced stages.  Conclusion: In our experience, the role of telemedicine was limited, regarding the opportune diagnosis of genitourinary cancer, given that the majority of cases analyzed were diagnosed in advanced stages.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Telemedicine]]></kwd>
<kwd lng="en"><![CDATA[Urology]]></kwd>
<kwd lng="en"><![CDATA[Genitourinary cancer]]></kwd>
<kwd lng="es"><![CDATA[telemedicina]]></kwd>
<kwd lng="es"><![CDATA[urología]]></kwd>
<kwd lng="es"><![CDATA[cáncer genitourinario]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[AlDossary]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Martin-Khan]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Bradford]]></surname>
<given-names><![CDATA[NK]]></given-names>
</name>
<name>
<surname><![CDATA[Armfield]]></surname>
<given-names><![CDATA[NR]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Development of a Telemedicine Planning Framework Based on Needs Assessment]]></article-title>
<source><![CDATA[J Med Syst]]></source>
<year>2017</year>
<volume>41</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>74</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>Secretaría de Salud</collab>
<source><![CDATA[Cuatro Experiencias de Telemedicina en México]]></source>
<year>2013</year>
<edition>2</edition>
<page-range>22</page-range><publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Secretaría de Salud/CENETE-SALUD]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>Secretaría de Salud</collab>
<source><![CDATA[Volumen 3 Telemedicina. Telemedicina]]></source>
<year>2011</year>
<volume>3</volume>
<edition>2</edition>
<page-range>216</page-range><publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Secretaría de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sandip]]></surname>
<given-names><![CDATA[Prasad]]></given-names>
</name>
<name>
<surname><![CDATA[Amit]]></surname>
<given-names><![CDATA[Patel]]></given-names>
</name>
<name>
<surname><![CDATA[Alex]]></surname>
<given-names><![CDATA[Rosen]]></given-names>
</name>
<name>
<surname><![CDATA[Tina]]></surname>
<given-names><![CDATA[Shih Ya-Chen]]></given-names>
</name>
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[Eggener]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[410 association of global incidence and mortality of genitourinary cancers with social and economic development]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>2012</year>
<volume>187</volume>
<numero>^s4</numero>
<issue>^s4</issue>
<supplement>4</supplement>
<page-range>e167-8</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<collab>Secretaría de Salud</collab>
<source><![CDATA[Modelo de Atención Médica a Distancia]]></source>
<year>2013</year>
<edition>1</edition>
<page-range>21</page-range><publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Secretaría de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kamel]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Moore]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Bissada]]></surname>
<given-names><![CDATA[NK]]></given-names>
</name>
<name>
<surname><![CDATA[Heshmat]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Potential years of life lost due to urogenital cancer in the United States: trends from 1972 to 2006 based on data from the SEER database]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>2012</year>
<volume>187</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>868-71</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferlay]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Soerjomataram]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ervik]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dikshit]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Eser]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mathers]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 v1.0]]></source>
<year>2012</year>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viers]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Lightner]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Tollefson]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
<name>
<surname><![CDATA[Boorjian]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Karnes]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficiency, satisfaction, and costs for remote video visits following radical prostatectomy: A randomized controlled trial]]></article-title>
<source><![CDATA[Eur Urol]]></source>
<year>2015</year>
<volume>68</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>729-35</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viers]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Pruthi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[O&#8217;Neil]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Gardner]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Jenkins]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Are Patients Willing to Engage in Telemedicine for Their Care: A Survey of Preuse Perceptions and Acceptance of Remote Video Visits in a Urological Patient Population]]></article-title>
<source><![CDATA[Urology]]></source>
<year>2015</year>
<volume>85</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1233-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hawary]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Warburton]]></surname>
<given-names><![CDATA[HE]]></given-names>
</name>
<name>
<surname><![CDATA[Brough]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Collins]]></surname>
<given-names><![CDATA[GN]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[O&#8217;Reilly]]></surname>
<given-names><![CDATA[PH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The &#8216;2-week wait&#8217; rule for referrals for suspected urological cancers--urgent need for refinement of criteria]]></article-title>
<source><![CDATA[Ann R Coll Surg Engl]]></source>
<year>2008</year>
<volume>90</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>517-22</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
